首页 | 本学科首页   官方微博 | 高级检索  
     

肝移植术后完全停用免疫抑制剂三例儿童临床特点分析
引用本文:宁禹,张明满,郭春宝,唐艳,吴娟. 肝移植术后完全停用免疫抑制剂三例儿童临床特点分析[J]. 中华小儿外科杂志, 2017, 0(8): 572-574. DOI: 10.3760/cma.j.issn.0253-3006.2017.08.004
作者姓名:宁禹  张明满  郭春宝  唐艳  吴娟
作者单位:400014 重庆医科大学附属儿童医院肝胆外科,儿童发育疾病研究教育部重点实验室,儿童发育重大疾病国家国际科技合作基地,儿科学重庆市重点实验室
基金项目:National Key Clinical Specialty Construction Project(NHFPC-2013-544),Scientific & Technological Projects of Chongqing (cstc2014yykfA110014)国家临床重点专科建设项目(国卫办医函[2013]544),重庆市科技计划项目(cstc2014yykfA110014)
摘    要:目的 探讨肝移植术后完全停用免疫抑制剂儿童的临床特征,寻找可能与术后免疫耐受形成有关的因素.方法 回顾性分析我院2008年7月至2009年6月间完成的儿童肝移植中完全停用免疫抑制剂的3例患儿资料,包括:移植年龄、原发疾病、供肝来源、术后免疫抑制剂、随访检查结果等.结果 3例完全停药儿童的原发病均为胆道闭锁,平均移植年龄7个月17 d,均为母体活体供肝肝移植,肝移植术后免疫抑制剂方案均为强的松龙+环孢素A,服药至少2年以上,完全停药1年以上.结论 移植年龄<1岁、原发病为胆道闭锁、母体供肝、服药2年以上、服用环孢素A是这些完全停药儿童的共同特征.

关 键 词:肝移植  免疫耐受  儿童

Clinical characteristics of complete immunosuppression withdrawal in pediatric recipients: a report of 3 cases
Ning Yu,Zhang Mingman,Guo Chunbao,Tang Yan,Wu Juan. Clinical characteristics of complete immunosuppression withdrawal in pediatric recipients: a report of 3 cases[J]. Chinese Journal of Pediatric Surgery, 2017, 0(8): 572-574. DOI: 10.3760/cma.j.issn.0253-3006.2017.08.004
Authors:Ning Yu  Zhang Mingman  Guo Chunbao  Tang Yan  Wu Juan
Abstract:Objective To explore the clinical characteristics of complete immunosuppression withdrawal in pediatric recipients and identify potential factors associated with immune tolerance.Methods The clinical data from 3 children undergoing liver transplantation between July 2008 and June 2009 at Children's Hospital were retrospectively analyzed,including age of donor/recipient at transplantation,transplant mode,primary disease and examination results.Results All primary diseases were biliary atresia and all cases of liver transplantation belonged to maternal living donor liver transplantation (LDLT).Primary immunosuppressant was cyclosporine A.And all patients had completely withdrawn medications for at least 1 year.Conclusions Age under 1 year,primary disease of biliary atresia,maternal LDLT,dosing for at least 2 years and primary drug of cyclosporine A are the common clinical characteristics among these patients.
Keywords:Liver transplantation  Immune tolerance  Child
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号